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Abstract
Biomonitoring studies are helpful tools and can increase our knowledge on time trends in human blood concentrations of
PFASs: how they relate to emission trends and the potential prenatal exposure for future generations. In this study,
serum was sampled in cross-sections of men and women who were 30 years old in each of the years 1986, 1994, 2001,
and 2007 in Northern Norway and analyzed for 23 PFASs. Differences in serum concentrations across sampling years
were investigated graphically and with significance testing and compared with those observed in our previous longitu-
dinal study using repeated individual measurements in older men in the same years. The results demonstrate overall
increasing blood burdens of PFASs in men and women in reproductively active ages during 1986–2001 and decreases
until 2007. However, longer chained PFASs were still increasing in 2007 indicating divergent time trends between the
different PFASs, underlining the importance of continued biomonitoring. Comparisons between 30-year-old men and
older men within the same population demonstrated variation in time trends in the exact same years, underlining that
biomonitoring studies must regard historic exposures and birth cohort effects.
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Introduction
Perfluoroalkyl substances (PFASs) have been produced since
the 1950s and used in a variety of consumer products due to
their chemical properties (Lehmler 2005). The production of
PFASs increased from 1966 to the 1990s and remained rather
constant from 1990 to 2000 until a phase-out was announced
by the 3M Company in 2000 (Paul et al. 2009). This resulted
in a rapid drop in production and use of perfluorooctane sul-
fonate (PFOS) related compounds from the year 2002 (Paul
et al. 2009). Several PFASs persist in the environment, have
the potential to bioaccumulate, and may have toxic effects in
animals and humans. Accordingly, the use of PFOS was re-
stricted in the USA in 2001 (Paul et al. 2009) and in Europe
from June 2008 (European Parliament 2006). In the USA,
eight of the major perfluorooctanoic acid (PFOA)–producing
companies committed to reduce emissions of PFOA and re-
lated chemicals by 95% by 2010 through the “PFOA
Stewardship Program” (US EPA 2006) and a wide ban of
PFOA by EU was implemented the 4th of July 2020
(European Parliament 2020). Additionally, PFOS and PFOA
have been classified as persistent organic pollutants (POP)
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(UNEPA 2015). In Norway, the main emissions of PFOS
have been through the use of fire-fighting foams with an esti-
mated use of 57,600 tons in 2005, in addition to 21,500 tons of
PFOS and related compounds remaining in stored products
(Norwegian Ministry of the Environment 2005). Production,
import, and export of PFOA or PFOA-containing products
and textiles were banned in Norway from June 1, 2014, as
well as the trade in such products produced prior to this date
(Norwegian Ministry of the Environment 2013). Following
voluntary and regulatory initiatives to minimize PFAS expo-
sures, the global production of PFOS and related chemicals
decreased substantially between 1990 and 2000 (Paul et al.
2009). However, the production of longer chain PFASs has
likely continued for some years after 2002 (Armitage et al.
2009), and the production of PFOS has continued in China
(Zhang et al. 2013). Additionally, the use of the aforemen-
tioned PFASs is often substituted with other PFASs, and in
2015 there were 3000 PFASs available on the global market
(Kemi 2015).
Despite decreased production and emissions, PFASs reside
in environmental compartments and humans are continuously
exposed to several of PFASs in their everyday life, primarily
through food, but also through water, air, and dermal contact.
Concerns for potential health effects of PFAS concentrations in
background-exposed populations are therefore still expressed.
Biomonitoring data provides a critical tool for evaluating the
effectiveness of the voluntary and regulatory initiatives, and
most studies report decreasing PFAS concentrations in human
serum after the year 2000, with significant declines of PFOS
and PFOA (Reviewed in Land et al. 2018). However, trends for
the longer chained PFASs like perfluoronanoic acid (PFNA),
perfluorodecanoic acid (PFDA), and perfluoroundecanoic acid
(PFUnDA) have been inconsistent across populations (Calafat
et al. 2007; Glynn et al. 2012; Jain 2018; Kato et al. 2011; Liu
et al. 2015; Olsen et al. 2017; Salihovic et al. 2015; Schroter-
Kermani et al. 2012). Furthermore, in cross-sectional studies
assessing human exposure to PFASs, concentrations have fre-
quently been reported to be positively associated with age and
to birth cohorts (Haug et al. 2009). However, in such study
designs, age and birth cohort effects are confounded (Glenn
1981; Quinn et al. 2011) and a study on temporal trends from
2002 to 2013 reported higher blood concentrations of certain
PFASs in younger compared to older individuals in Australia
(Eriksson et al. 2017). Our research group has previously re-
ported intra-individual trends in PFASs concentrations using
five repeated measurements during 1979–2007 in serum from
53 aging men (Nøst et al. 2014). In that study, we concluded
that a person’s lifetime environmental exposure to PFASs (i.e.,
the intensity and duration of their environmental exposure) de-
pends on when they were born relative to the time of peak
environmental concentrations. To further extend our under-
standing of the time trends of PFASs in relation to age and birth
cohorts, the present study assessed PFAS concentrations in
repeated cross-sectional samples of 30-year-olds in the period
1986 to 2007 and compared trends to those in older men in the
same geographical region. Furthermore, the age group repre-
sented reproductively active ages and could indicate potential
prenatal exposure for future generations.
Material and methods
Study population
The Tromsø study is a health survey that has occurred every
seventh year in the municipality of Tromsø, Northern Norway
(summarized by; Jacobsen et al. 2011). We included men and
women who were 30 years old when they donated blood in
four surveys in the period 1986 to 2007. Participants who had
sufficient sample volumes in 1986 (n = 29), 1994 (n = 29),
2001(n = 29), and 2007 (n = 30) were included; thus, the
present analyses comprised 117 serum samples. Socio-
demographic and lifestyle information was extracted from
questionnaires. Serum samples were stored at −70 °C until
analysis.
Analytical methodology
A total of 23 PFASs, 13 perfluoroalkyl carboxylic acids (C4-
C14, C16, C18), six perfluoroalkyl sulfonates (C4-C8, C10),
three fluorotelomer sulfonates (4:2, 6:2, 8:2), and one
perfluroalkyl sulfonamide (C8), were analyzed in serum sam-
ples at the laboratory at NILU–Norwegian Institute for Air
Research, Fram Centre, Tromsø, Norway using sonication-
facilitated liquid-liquid extraction with methanol, activated
ENVI-carb clean-up (Powley et al. 2005) and analysed by
ultrahigh pressure liquid chromatography triple–quadrupole
mass spectrometry (UHPLC-MS/MS). The procedures for
sample preparation, treatment, and extraction are previously
published byHanssen et al. (2013). The only changes were the
volumes used; 2.5 ng internal standard mixture was added to
0.25ml serum before the addition of 1 ml methanol and 2.0 ng
branched PFDA was added as the recovery standard. An ali-
quot of 100 μl extract was transferred to a vial and mixed with
an equal amount of 2 mM aqueous ammoniumacetate
(NH4OAc, ≥99%, Sigma-Aldrich, St. Louis, MO, USA) prior
to analysis. The analytical method, instrumentation, and re-
agents are described in detail by Hanssen et al. (2013). Details
on compounds, detection rates, and limit of detections (LODs)
are presented in Table S1 in the supplemental material.
Quality control in PFAS analyses
To assure the quality of the PFAS analyses, repetitive anal-
ysis of blank samples and reference samples were per-
formed. The laboratory also participates in the Artic
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Monitoring and Assessment Programme ring test for POPs
in human serum, an international comparison program, or-
ganized by Institut National de Santé Publique du Québec,
Canada (Québec Indspd 2014). The uncertainties of our
analyses are within ±15 to 20% of the assigned values, in-
dicated by Interlaboratory comparisons and reference sam-
ples. Quantification of the contaminants was performed by
the internal standard addition method using isotope-labeled
PFASs (Hanssen et al. 2013). In all samples, concentrations
of PFAS were within the linear range of the instrument and
the calibration curve. A second mass transition served to
confirm compound specificity for each compound in the
mass spectrometry analyses. The linear PFOS isomers were
chromatographically separated from the branched isomers
and quantified separately. Summed concentrations of the
PFOS isomers (branched PFOS + linear PFOS) were con-
sidered in the statistical analyses unless otherwise stated.
The LOD was calculated as 3× the signal to noise
(background) ratio.
Data treatment and statistical analyses
All statistical analyses were conducted using STATA (version
16.1; Statacorp, Texas, USA) and a statistical significance
threshold of p < 0.05 was used. Only PFASs with detection
frequencies above 70% were evaluated in the statistical
models, and concentrations below the LOD were replaced
by LOD/√2. Spearman’s ρ values were calculated for correla-
tions and we used the nonparametric test Wilcoxon rank sum
test to test differences in PFAS concentrations between sam-
pling years and sex.
Results
Study sample characteristics and PFAS concentrations
Characteristics of study participants are presented in Table 1.
The proportion of men and women was unequally distributed
across the sampling time points and the percentage of women
were 55, 62, 48, and 66 % in 1986, 1994, 2001, and 2007,
respectively. Median body mass index (BMI) was significant-
ly higher in 30-year-olds in 2001 and 2007 compared to 1986
(Table 1), and BMI was slightly higher in men compared to
women at all time points (results not shown). Serum concen-
trations of PFASs in men and women at each sampling year
are presented in Table 2. Eight PFASs were detected in >70%
of all the samples. PFOS was detected in highest concentra-
tions in all sampling years followed by PFOA and
perfluorooctane sulfonamide (FOSA) (except for in 2007),
whereas the magnitude of concentrations of perfluorohexane
sulfonate (PFHxS), perfluoroheptane sulfonate (PFHpS),
PFNA, PFDA, and PFUnDA varied according to sampling
year (Table 2 and Fig. 1).
Differences in PFAS concentrations between sexes
Concentrations in women and men in the different sampling
years are depicted in Fig. 2. Women had lower concentrations
of PFASs compared to men at all time points (Fig. 2 and
Table 2), and the differences were significant (Wilcoxon rank
sum test p-values <0.05) for PFHxS (in 1986, 1994, and
2007), PFHpS (in 1986 and 1994), PFOS (in 1994, 2001
and 2007), and PFOA (in 1994) and PFNA (in 2001). The
Table 1 Characteristics of 30-
year-olds in four population
surveys in the Tromsø Study
Sampling year 1986 1994 2001 2007
Age 30 30 30 30
Birth year 1956 1964 1971 1977
Men (n) 13 11 15 10
Women (n) 16 18 14 20
Median BMI (5, 95 percentiles) 23 (20, 27) 24 (20, 36) 25 (19, 32) 25 (20, 33)
No. of child births (% of all women)a
0 4 (25) 9 (50) 6 (43) 12 (60)
1 3 (19) 3 (17) 4 (29) 4 (20)
2 9 (56) 5 (28) 3 (21) 4 (20)
3 - 1(5) - -
4 - - 1 (7) -
Birth year of children NAb 1985–1994 1991–2000 1995–2007
Median birth year first child NAb 1988 1994 2000
Median total breastfeeding months NAb 9 8 11
a For 1986 and 1994, there were 1 and 3 women, respectively, that did not report any explicit number of children
nor any details of any child birth in the questionnaires. These were assumed not to have children. bNA, not
available; (n), number of subjects. BMI, body mass index (kg/m2 )
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% branched PFOS were lower for women compared to the
men at all time points (not significantly in 1986) and were 39,
43, 40, and 42% for women and 45, 45, 44, and 52% for men
in 1986, 1994, 2001, and 2007, respectively. In 1986 and
2004, multiparous women had lower median concentrations
of FOSA compared to women who had not given birth (not
statistically tested), whereas there were no differences in the
other PFAS concentrations according to parity in these years.
Multiparous women had lower median concentrations of
FOSA, PFHxS, PFHpS, PFOS, and PFOA in 2001 and lower
Table 2 Concentrations (ng/ml) of perfluoroalkyl substances in serum from 30-year-olds in four different surveys of the Tromsø study
Women 1986 n = 16 1994 n = 18 2001 n = 14 2007 n = 20
Median Min Max Median Min Max Median Min Max Median Min Max
FOSA 0.54 0.15 4.61 1.15 0.30 3.70 0.61 0.17 1.65 - - -
PFHxS 0.26 0.07 0.91 0.52 0.15 1.23 0.63 0.25 7.74 0.47 0.05 0.97
PFHpS 0.10 <LOD 0.36 0.15 <LOD 0.58 0.26 <LOD 1.39 0.13 <LOD 0.47
ΣPFOS 15.3 9.15 34.9 22.7 6.52 53.2 28.1 8.51 65.7 10.6 3.88 24.4
PFOS linear 8.82 5.37 18.0 13.2 4.20 30.2 16.6 4.99 35.8 6.06 2.53 14.2
PFOS branched 6.34 3.42 16.9 8.96 2.32 23.0 11.5 2.97 29.9 4.31 1.34 10.2
PFOA 1.97 0.94 3.98 3.64 1.08 6.97 2.89 0.68 5.31 2.37 0.81 7.22
PFNA 0.21 <LOD 0.39 0.30 <LOD 0.40 0.29 <LOD 0.75 0.59 0.23 1.47
PFDA 0.05 <LOD 0.13 0.14 <LOD 0.26 0.17 0.06 0.43 0.21 0.06 0.59
PFUnDA 0.26 <LOD 0.81 0.18 <LOD 0.40 0.16 <LOD 0.70 0.23 <LOD 1.12
ΣPFAS 19.3 11.2 43.1 29.2 8.92 64.9 34.8 10.5 76.0 16.0 6.58 31.8
Men 1986 n = 13 1994 n = 11 2001 n = 15 2007 n = 10
Median Min Max Median Min Max Median Min Max Median Min Max
FOSA 0.84 0.17 3.44 1.09 0.15 4.49 0.59 0.24 2.78 - - -
PFHxS 0.74 0.39 3.40 1.19 0.70 2.22 1.42 0.61 3.85 1.29 0.67 3.25
PFHpS 0.24 <LOD 0.33 0.44 0.22 0.75 0.49 0.25 0.89 0.30 <LOD 1.46
ΣPFOS 21.7 10.1 47.4 41.1 24.8 63.9 41.6 23.9 53.9 20.1 14.5 49.1
PFOS linear 13.3 5.31 26.0 22.2 13.8 37.1 23.2 12.5 36.3 9.28 7.75 30.5
PFOS branched 8.13 4.77 21.3 18.5 9.87 27.0 17.5 10.5 27.1 11.4 6.77 19.5
PFOA 3.31 1.02 7.84 4.92 3.36 15.1 4.16 2.69 7.72 3.44 1.77 7.72
PFNA 0.33 0.22 0.64 0.46 0.23 0.63 0.54 0.36 0.76 0.53 0.41 1.09
PFDA 0.08 <LOD 0.14 0.19 0.11 0.49 0.26 0.12 0.49 0.23 0.07 0.51
PFUnDA 0.33 0.16 1.02 0.22 0.10 0.63 0.31 <LOD 0.78 0.22 <LOD 0.68
ΣPFAS 25.8 12.8 61.1 52.5 34.1 74.0 49.4 30.2 63.5 26.4 19.9 59.3
FOSA, perfluorooctane sulfonamide; PFHxS, perfluorohexane sulfonate; PFHpS, perfluoroheptane sulfonate; ∑PFOS, sum perfluorooctane sulfonate;
PFOA, perfluorooctanoic acid; PFNA, perfluoronanoic acid; PFDA, perfluorodecanoic acid; PFUnDA, perfluoroundecanoic acid; ΣPFASs, sum
perfluoroalkyl substances
Fig. 1 Relative contributions of
individual PFASs to their sum (in
%) in serum samples in 1986,
1994, 2001, and 2007 in men and
women
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concentrations of all detected PFASs in 2007 compared to
women who had not given birth (Table S2).
PFAS concentrations across surveys
The median summed (Σ) PFAS concentrations increased
from 1986 to 2001 in women, and from 1986 to 1994 in
men (Table 3). Concentrations in 2007 relative to 2001
decreased by half for both sexes (54% and 47% for wom-
en and men, respectively). For the individual compounds,
median concentrations of PFHpS, PFHxS, and PFOS in-
creased from 1986 to 2001 in both men and women,
followed by a decline from 2001 to 2007. PFOA followed
the same pattern but demonstrated peak concentrations in
1994. In comparison, concentrations of PFNA and PFDA
were higher in 2007 compared to 2001 in women and
were rather unchanged across the same years in men.
For PFUnDA, no specific time trends between sampling
years were observed. FOSA had the third highest concen-
trations in 1986 and 1994 but concentrations dropped sig-
nificantly from 1994 to 2001 (p < 0.05), and FOSA was
not detected above LOD in any of the samples in 2007.
The correlations of PFASs within sampling years are
presented in Table S3. Correlations between PFOS and
PFOA decreased across the period (rs = 0.70, 0.76, 0.63,
and 0.51 in 1986, 1994, 2001, and 2007, respectively),
whereas correlations between PFNA, PFDA, and
PFUnDA increased during the period (rs = 0.60, 0.71,
0.73, and 0.75 between PFNA and PFDA in 1986,
1994, 2001, and 2007, respectively).
Comparing time trends in different study designs
The overall time trends in the period 1986 to 2007 were
similar between 30-year-old men and the older men from
the same population surveys (Fig. 3), whereas the median
concentrations of several PFASs and the relative increase
and decrease between surveys differed. The observed rela-
tive decreases from 2001 to 2007 in 30-year-old men were
−9%, −38%, and −52% for PFHxS, PHFpS, and PFOS,
respectively and the corresponding decreases for the same
sampling years in the older men were −6%, −13%, and
−22%. PFNA, PFDA, and PFUnDA concentrations de-
creased in the 30-year-olds but increased in the older men,
whereas both study sample sets decreased similarly in PFOA
concentrations. Concentrations and time trends in men in the
present study were comparable to results from a previous
study from Norway, including repeated cross-sectional sam-
ples of pooled blood from men in the age group 40–50 years
old (Haug et al. 2009); however, PFOS concentrations in the
30-year-olds in Northern Norway were higher than concen-
trations in the 40–50-year-old men at all time points (17
versus 15; 27 versus 24; 33 versus 27; and 13 versus 12
ng/ml PFOS in 1986, 1994, 2001, and 2007 respectively).
Figure 3 displays only the comparison between men as no
comparable study was found that included only women.
Fig. 2 PFAS concentrations in serum from 30-year-old men (blue boxes)
and women (orange boxes) in the years 1986, 1994, 2001, and 2007.
Ranges on the Y-axis vary across components. Boxes represent the
25th–75th percentiles, horizontal lines represent the median, whiskers
indicate 1.5 times the length of the interquartile range above and below
the 75th and 25th percentiles, respectively, and outliers are represented as
data points
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Discussion
This study reports individual concentrations of PFAS in men
and women in reproductively active ages during a period of 22
years before and after peak emissions. We demonstrate that
concentrations of several PFASs in 30-year-old men and
women in Northern Norway have decreased considerably
since the year 2000. The cross-sectional serum time trends
of PFASs in men and women were increasing from 1986 to
2001 followed by a decrease to 2007 for PFHxS, PFHpS, and
PFOS. Furthermore, PFOA concentrations were the highest in
1994 and decreased towards 2007. However, increasing con-
centrations were observed for PFNA, PFDA, and PFUnDA,
and this result stresses the importance of continued biomoni-
toring of human exposure to these environmental pollutants.
Concentrations of PFASs were lower in women as compared
tomen at all time points, and in 2001 and 2007, concentrations
were lower in multiparous women compared to women who
had not given birth. The age group of 30-year-olds in this
study was chosen to represent reproductively active ages in
Northern Norway. This study group was targeted to provide
relevant monitoring results for human exposure but especially
to indicate prenatal exposure for future generations.
Accordingly, our study demonstrates that early life exposures
to PFASs through breastfeeding have been extensively re-
duced since the year 2000. In the present study, similar to
previous studies, our findings suggest that human blood con-
centrations reflect historic production and use of PFASs in the
subsequent years (Paul et al. 2009).
The present results demonstrate a mean annual decrease in
PFOS from 2001 to 2007 of 8.9% in women and 7.4% inmen,
whereas PFOA decreased annually by 2.5% in women and
2.1% in men from 1994 to 2007. These results are in line with
results from both longitudinal and cross-sectional studies from
the same period (Glynn et al. 2012; Haug et al. 2009; Nøst
et al. 2014; Schroter-Kermani et al. 2012). Glynn and col-
leagues investigated temporal trends of PFASs in pooled se-
rum from Swedish primiparous women in the period 1996 to
2010. They reported a yearly decrease in PFOS and PFOA of
8.4% and 3.1%, respectively. In the present study, PFNA and
Table 3 Difference in median concentrations (ng/ml) of perfluoroalkyl substances in 30-year-olds between survey years



















FOSA Women 0.61 0.087 113 −0.54 −0.077 −47 - - -
PFHxS Women 0.26 0.037 100 0.11 0.016 21 −0.16 −0.023 −25
PFHpS Women 0.05 0.007 50 0.11 0.016 73 −0.13 −0.019 −50
ΣPFOS Women 7.40 1.057 48 5.40 0.771 24 −17.5 −2.500 −62
PFOS linear Women 4.38 0.626 50 3.40 0.486 26 −10.5 −1.506 −63
PFOS branched Women 2.62 0.374 41 2.54 0.363 28 −7.19 −1.027 −63
PFOA Women 1.67 0.239 85 −0.75 −0.107 −21 −0.52 −0.074 −18
PFNA Women 0.09 0.013 43 −0.01 −0.001 −3 0.30 0.043 103
PFDA Women 0.09 0.013 180 0.03 0.004 21 0.04 0.006 24
PFUnDA Women −-0.08 −0.011 −31 −0.02 −0.003 −11 0.07 0.010 44
ΣPFASs Women 9.9 1.414 51 5.60 0.800 19 −18.8 −2.686 −54
FOSA Men 0.25 0.036 30 -0.50 −0.071 −46 - - -
PFHxS Men 0.45 0.064 61 0.23 0.033 19 −0.13 −0.019 −9
PFHpS Men 0.20 0.029 83 0.05 0.007 11 −0.19 −0.027 −39
ΣPFOS Men 19.4 2.771 89 0.50 0.071 1 −21.5 −3.071 −52
PFOS linear Men 8.90 1.271 67 1.00 0.143 5 −13.9 −1.989 −60
PFOS branched Men 10.4 1.481 128 -1.00 −0.143 −5 −6.10 −0.871 −35
PFOA Men 1.61 0.230 49 -0.76 −0.109 −15 −0.72 −0.103 −17
PFNA Men 0.13 0.019 39 0.08 0.011 17 −0.01 −0.001 −2
PFDA Men 0.11 0.016 138 0.07 0.010 37 −0.03 −0.004 −12
PFUnDA Men −0.11 −0.016 −33 0.09 0.013 41 −0.09 −0.013 −29
ΣPFASs Men 26.7 3.814 103 −3.10 −0.443 −6 −23.0 −3.286 −47
FOSA, perfluorooctane sulfonamide; PFHxS, perfluorohexane sulfonate; PFHpS, perfluoroheptane sulfonate; ∑PFOS, sum perfluorooctane sulfonate;
PFOA, perfluorooctanoic acid; PFNA, perfluoronanoic acid; PFDA, perfluorodecanoic acid; PFUnDA, perfluoroundecanoic acid; ΣPFASs, sum
perfluoroalkyl substances
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PFDA concentrations increased annually from 1986 to 2007
by 8.6 % and 15% in women, and 2.9% and 8.9% in men,
indicating a continued exposure to these PFASs. However,
recent studies show divergent temporal trends for the longer
chained PFASs. A study fromDenmark investigated temporal
trends in nulliparous women from 2008 to 2013 and demon-
strated decreasing concentrations of the longer chained PFASs
throughout the period (Bjerregaard-Olesen et al. 2016),
whereas a study from Australia demonstrated increasing con-
centrations from 2002 to 2013 for some of the longer chained
PFASs (Eriksson et al. 2017).
The overall time trends in the period 1986 to 2007 were
similar between 30-year-old men and in older men from the
same population sampled in the same years (Nøst et al. 2014)
in that PFOS, PFHxS, PFHpS, PFOA, and FOSA increased
until peak emissions around 2001 and decreased thereafter,
and PFNA, PFDA, and PFUnDA increased throughout the
study period. Concentrations of PFHxS, PFHpS, and especial-
ly PFNA, PFDA, and PFUnDA were higher in the older men
as compared to the younger men, whereas concentrations of
PFOS, PFOA, and FOSA were similar across these two age
groups. Median concentrations of PFOS were similar in 30-
year-old men and the older men in 1986, 1994, and 2001,
whereas lower for the younger men in 2007 (20 versus 33
ng/ml, respectively). Concentrations of PFOA were compara-
ble in 1986 (3.3 versus 2.5, respectively) and in 1994 (4.9
versus 3.9 ng/ml, respectively) and similar in 2001.
Accordingly, the 30-year-old men in 1986, 1994, and 2001
were born before or in the period of increasing production of
PFASs, and should theoretically have experienced the same
average PFAS exposure as the older men (born between 1925
and 1950). The decrease in concentrations of PFOS between
2001 and 2007 was larger in the 30-year-old men compared to
the older men. Those who were 30 years old in 2007 were
born in 1977, and have, based on marked increases in estimat-
ed emissions of PFASs in these years (Paul et al. 2009), ex-
perienced different exposure scenarios from birth compared to
the older study group born in 1925–1950. In accordance with
such interpretation of biomonitoring trends in relation to past
emission and use, comparing intra- and inter-individual
polychlorinated bisphenol (PCB) and organochlorine pesti-
cide (OCP) concentrations in the same study samples (Nøst
et al. 2019), we demonstrated that PCB and OCP concentra-
tions in 30-year-olds decreased with decreasing exposures and
were lower in each sampling year compared to the older men
(Nøst et al. 2013) due to higher historic exposure in the older
birth cohorts. Furthermore, the decreasing concentrations be-
tween 2001 and 2007 in 30-year old men were more pro-
nounced as compared to the trends observed in the aging
men which was also observed for PCBs and OCPs (Nøst
et al. 2019). For example, the median decrease in PFOS be-
tween 2001 and 2007 in 30-year-old men was 52% compared
Fig. 3 Comparing PFAS concentrations (ng/ml) across sampling year (y-
axis) in the two Norwegian repeated cross-sectional (CS) sampling of 30-
year-old men (present study) or 40–50-year-old men (Haug et al. 2009),
and the longitudinal (LT) study with repeated individual measurements in
older men (median age increase from 50 to 71 between 1986 and 2007)
(Nøst et al. 2014)
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to 22% in the aging men. However, the design differs between
these observations as in the study with repeated serum sam-
ples in the same individuals; the birth cohorts were fixed and
the age increased chronologically, whereas in the present
study, the age is fixed and the birth cohorts are more recent
between each population survey. Therefore, the differences in
decreases between the age groups is likely a result also of the
different study designs as one can expect smaller differences
in one individual over time (intra-individual difference) com-
pared to between different individuals (inter-individual differ-
ence). Also, a steeper decline in several PFASs in 30-year-old
men compared to older men may partly be explained by a
decrease in intake of fish in the younger men, as trends has
shown a decreasing intake of fish in younger people in
Norway over the last years (Norwegian Directorate of
Health 2019). Still, PFOS in our study sample was higher at
all time points compared to concentrations in pooled serum
from 40- to 50-year-old men from all over Norway (Haug
et al. 2009). Overall, our results demonstrate that changes in
human exposure to PFASs across calendar years reflect
change in emissions and environmental concentrations, thus
individual concentrations of PFASs depend on birth cohort
and exposure history.
Median concentrations in women were significantly lower
than for men for several PFASs in all four surveys. This has
been observed in most studies comparing concentrations of
PFASs in men and women (Coakley et al. 2018; Goralczyk
et al. 2015) and is probably largely due to the elimination
routes through childbirth, breastfeeding, and menstruation in
women (Harada et al. 2005; Haug et al. 2011; Rush et al.
2018; Wong et al. 2014). Similar, in men, the percentage of
branched PFOS was higher compared to women at all time
points, and this has been reported in other studies as well (Liu
et al. 2015; Rylander et al. 2009; Zhang et al. 2014). This
indicates different accumulation and elimination patterns of
PFOS in men and women and may be due to a higher elimi-
nation rate of branched PFOS by placental transfer during
pregnancy (Beesoon et al. 2011; Hanssen et al. 2010). As
toxicokinetics for several PFAS have been demonstrated to
be similar across sexes (Harada et al. 2005), observed differ-
ences in concentrations between sexes are likely due to elim-
ination routes of PFASs present only in women. This is sup-
ported by that parity, breastfeeding duration, and the use of
contraceptives have been important predictors of PFAS con-
centrations in women (Berg et al. 2014; Brantsæter et al. 2013;
Haug et al. 2011; Rush et al. 2018).
Overall, the observed PFAS concentrations in our study
sample are in line with the concentration ranges of PFASs in
the period 1986–2007 reported for both women and men by
other studies from overlapping sampling periods (Berg et al.
2014; Eriksson et al. 2017; Haug et al. 2009; Jain 2018; Kato
et al. 2011; Nøst et al. 2014; Schroter-Kermani et al. 2012).
However, concentrations in the 30-year-olds in the present
study were slightly higher compared to concentrations report-
ed from other studies including this age group in comparable
sampling years in Norway. For example, pregnant women
aged 30–34 years from the Norwegian Mother, Father and
Child Cohort Study (MoBa) sampled in 2003–2004
(Brantsæter et al. 2013) had lower median concentrations of
PFOS and PFOA compared to the 30-year-old women in
Tromsø in 2001 (11.9 versus 28.1 and 1.91 versus 2.89 ng/ml,
respectively) and may be due to higher exposure related to
higher intake of fish in people living in Northern Norway.
Accordingly, the Norwegian national dietary survey
(Norkost 3) reported a fish intake in the age group 30–39 years
of 106 and 91 g per day in men and women from Northern
Norway, respectively, versus 71 and 46 g per day for men and
women in the total population (Totland et al. 2012).
Regarding potential prenatal exposure for future generations
and potential adverse effect, EFSA has reported a lowest
benchmark dose (BMLD10) of 17.5 ng/ml for the sum of
PFNA, PFOA, PFHxS, and PFOS in serum in 1-year-old chil-
dren. This corresponds to a long-term maternal exposure of
0.63 ng/kg bodyweight per day and breastfeeding the child for
12 months. This would correspond to a pre-pregnancy mater-
nal serum concentration of 6.9 ng/ml at the age of 35 for these
PFASs. In comparison, the median concentrations of these
four PFAS in the 30-year-old women in the present study were
18, 28, 35, and 15 ng/ml in 1986, 1994, 2001, and 2007,
respectively. Thus, the observed concentrations indicated that
children were exposed to concentrations above the recom-
mended level for safe intake of these PFASs in the period
1986–2007 and that PFASs exposure for children is still a
concern although concentrations of PFASs are decreasing.
In the present study, multiparous women had lower median
concentrations of all PFASs in the years 2001 and 2007 com-
pared to nulliparous women and these results are in accor-
dance with the MoBa study who reported that parity was the
strongest predictor for concentrations of PFASs in their study
in pregnant women sampled in 2003–2004 (Brantsaeter et al.
2013). Except for FOSA, there were no differences in PFAS
concentrations according to parity in 1986 and 1994. There
were few nulliparous women among the women included in
the first two study years, which may have affected these dif-
ferences. These differences may also be influenced by the
relative importance of childbirth and breastfeeding as elimi-
nation sources for PFASs differ in pre- and post-ban periods.
As the time trends of PFOS and PFOA in human blood dem-
onstrate sharp declines between 2001 and 2003 (Harada et al.
2005; Harada et al. 2004; Inoue et al. 2004; Olsen et al. 2003;
Olsen et al. 2005), childbirth and breastfeeding after this pe-
riod would result in a more pronounced effect on maternal
blood concentrations compared to before the peak.
Accordingly, in a cohort of northern Norwegian pregnant
women, nulliparous women had higher PFAS concentrations
compared to multiparous women in 2007–2009 (for example,
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10 ng/mL versus 4.5 ng/mL in median PFOS, respectively)
(Berg et al. 2014), whereas in a study from Sweden, Ode et al.
(2013) did not observe differences in concentrations between
parity groups in the years 1978 to 2001.
PFOS, PFOA, and PFHxS were detected in all samples
across all sampling years, whereas the detection frequencies
of FOSA, PFHpS, PFNA, PFDA, and PFUnDA varied be-
tween the years. PFOS contributed most to the summed
PFASs in all years, and decreased the most from 2001 to
2007, followed by PFHpS, PFHxS, PFOA, and PFDA. This
result demonstrates the dominance of PFOS, as also observed
in other studies (Berg et al. 2014; Brantsaeter et al. 2013;
Calafat et al. 2006; Calafat et al. 2007; Glynn et al. 2012;
Haug et al. 2009). Concurrently, correlations within the
shorter chained PFASs (C6–C8) decreased during the sam-
pling period, while correlations between the longer chained
(C9–C11) increased. The compositional patterns and correla-
tions likely reflect the time passed since peak emissions, as
exposure sources have been diluted along with time and ac-
cording to half-lives of the compounds (Nøst et al. 2017).
Hence, increasing correlations between the longer chained
PFASs may indicate continued productions and common ex-
posure sources as well as longer half-lives, whereas decreased
correlations between the sulfonates may indicate eliminated or
reduced exposures and subsequent diluted exposure routes.
Finally, as FOSA and other preFOS can degrade to PFOS,
this might explain why the percentage of branched PFOS
were increasing and at its highest in 2007 in both men and
women. Accordingly, Glynn et al. (2012) reported a signifi-
cant increasing trend of branched PFOS between 2000 and
2010.
Fifteen of the targeted PFASs were not detected in the
study sample although several of these have been reported in
blood from other populations from the same study period
(Gebbink et al. 2015; Glynn et al. 2012; Miaz et al. 2020).
For example, detectable concentrations of PFBA, PFHxA,
PFHpA, PFTriDA, PFBS, 6:2 FTS, and 8:2 FTS have been
reported in primiparous women from Uppsala, Sweden (Miaz
et al. 2020). However, sample volumes extracted and detec-
tion rates differed between studies and could explain why it is
not detected in this study. Still, the low concentrations indi-
cated demonstrates the dominance of the PFASs presented in
this study and that the exposure to other PFASs is low in
Northern Norway.
This study included a limited number of samples and in-
cluded both men and women where the women were both
nulliparous and parous. This limited the statistical power and
led to a higher assumed variance, and we chose not to perform
statistical testing of differences in PFAS concentrations ac-
cording to parity. Furthermore, individual intake of dietary
variables was not available across the study period and we
could not assess if the time trends were affected by changes
in dietary habits across the study period. Also, information of
previous breastfeeding periods was not available for all wom-
en in the first sampling year. An important strength of this
study is that we have individual and not pooled data, enabling
us to assess individual variation in PFAS concentrations with-
in populations with the same age and over periods of time.
Conclusions
Median serum concentrations of PFASs in 30-year-old men
and women from four different sampling years reflected over-
all historic production and use of PFASs in this period. The
results demonstrated a decrease in blood burdens of PFASs in
men and women of reproductively active ages in the past two
decades. This study and our previous study in aging men
demonstrate differences in PFAS concentrations and time
trends according to age group, birth cohorts, and study de-
signs, and the importance of voluntary and regulatory initia-
tives for these substances.
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